Outbreak of Ceftazidime Resistance Due to a Novel Extended-Spectrum β-Lactamase in Isolates from Cancer Patients
AbstractCONTENT ALERTS Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), moreÂ» Information about commercial reprint orders: http://aac.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ Downloaded from http://aac.asm.org/ on November 19, 2011 by deepdyve ERRATUM Outbreak of Ceftazidime Resistance Due to a Novel Extended-Spectrum ,3-Lactamase in Isolates from Cancer Patients LOUIE NAUMOVSKI, JOHN P. QUINN, DEBORAH MIYASHIRO, MARLYNN PATEL, KAREN BUSH, SUSAN B. SINGER, DONNA GRAVES, TIM PALZKILL, AND ANN M. ARVIN Department of Pediatrics, Divisions of Hematology/Oncology and Infectious Diseases, Stanford University School of Medicine, and Clinical Microbiology Laboratory, The Children's Hospital at Stanford, Stanford, Califomia 94305; Department of Medicine, Division of Infectious Diseases, Humana Hospital-Michael Reese, Chicago, Illinois 60616; Medical Research Division, American Cyanamid, Pearl River, New York 10965; Phannaceutical Research Institute, Bristol-Myers Squibb, Pnnceton, New Jersey 08540; and Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas 77030 Volume 36, no. 9, p. 1993, Table 1: In the boxhead, "TEM-23" should read "TEM-26." Page 1994, Table 3, columns 3 and 4: The columns of data under the headings "TEM-9" and "TEM-26" should be transposed.